Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 Bekeken
• 07/10/23
0
0
insluiten
administrator
abonnees
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties